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Abstract: Alkoxysilane precursors are the most widely used silica source for sol–gel preparation of 
silicate-based bioactive glass. However, due to their high cost, alternative sources such as bentonite 
clay are desirable. In the present work, bentonite clay was reacted with sodium hydroxide (NaOH) to 
extract sodium metasilicate (Na2SiO3). The obtained Na2SiO3 was converted to gel which was then 
sintered at 950 ℃ for 3 h to give the bioactive glass in the quaternary composition SiO2–NaO–CaO– 
P2O5. The resulting glass was incubated in simulated body fluid (SBF) for 0–7 days to evaluate the 
bioactivity. Furthermore, glass samples were characterized before and after SBF study by scanning 
electron microscopy (SEM), energy dispersive X-ray spectroscopy (EDX), X-ray diffraction (XRD), 
and Fourier transform infrared spectroscopy (FTIR). Results obtained showed the presence of 
Na2Ca2Si3O9 (combeite) crystal as the major crystalline phase and the formation of hydroxyapatite 
(HA) and hydroxycarbonated apatite (HCA) on the surface of the glass after immersion in SBF. The 
material showed potentials for application as scaffold in bone tissue repair.  




The interest in bioactive glass has continued to soar 
particularly within the orthopaedic biomedical research 
community because of its ability to promote self-repair 
of damaged bones when used as temporary scaffold in 
vivo. The “gold standard” for bone treatment involves 
autograft and allograft transplantation. However, these 
methods have severe limitations and thus impose high 
cost on the health care system. The shortcomings 
associated with autograft include severe pain, 
morbidity of the harvested site, structural and 
anatomical problems, and high rate of resorption 
during healing [1,2]. Likewise, allograft may elicit 
disease transmission and rejection, further 
compounded by shortage of donors [3,4].  
The use of bioactive glass for bone restoration 
represents a paradigm shift from replacement to 
regeneration through the use of synthetic bone grafts as 
positive effort to address the aforementioned 
drawbacks. The unique capability of bioactive glass 
over other bioceramics includes amongst others the 
ability to form hydroxyapatite (HA) on the surface 
when immersed in physiological environment [5,6]. 
This is beneficial because of the similarity in chemical 
composition of HA to bone and therefore facilitates the 
bonding between the material and bone [7]. Other 
significance of bioactive glass in physiological 
environment is its ability to elicit osteoblastic activity 
and improvement of cell adhesion [8]. Indeed, it has 
been reported that seven families of genes are 
up-regulated by the ionic dissolution products from 
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bioactive glass [9]. 
Generally, sol–gel-derived glass, with its inherent 
mesoporosity, provides larger surface area and 
consequently more rapid degradation rate than 
melt-derived glass of similar composition [10,11]. 
Additionally, the sol–gel technology provides higher 
purity, homogeneity, and possibility of increasing the 
compositional range above 60 mol% while maintaining 
bioactivity of the glass [12]. 
Recently, our research group embarked on the search 
for new silica-based materials as economic synthetic 
substitutes to the widely used alkoxysilane precursors 
such as tetraethyl orthosilicate (TEOS) and tetramethyl 
othosilicate (TMOS). Consequently, we have reported 
the synthesis of bioactive glass from sand and clay 
using the sol–gel technique [13,14]. However, in our 
use of bentonite clay as a novel starting material [14], 
we did not evaluate the bioactivity of the obtained 
bioceramic, and to the best of our knowledge, no 
previous work on the bioactivity of sol–gel-derived 
bioactive glass from bentonite clay has yet been 
reported. Therefore, herein we report the bioactivity of 
quaternary bioactive glass in the system 
SiO2–Na2O–CaO–P2O5 obtained from bentonite clay.  
2    Materials and methods 
2. 1    Materials   
The chemicals for the preparation of the bioactive 
glass included: bentonite clay -(OH)4Si8Al4O20 ∙ nH2O 
(Ijero-Ekiti, Nigeria), sodium hydroxide (Sigma-   
Aldrich, 99%), nitric acid (HNO3, Fluka, Germany), 
phosphoric acid (H3PO4, BDH Laboratory, 98%), 
sodium nitrate (NaNO3, Sigma-Aldrich, 99%), and 
calcium nitrate tetrahydrate (Ca(NO3)2·4H2O, LOBA, 
98%). All chemicals were used as obtained without 
further purification. 
2. 2    Methods 
To prepare the bioactive glass with composition 
46.99 mol% SiO2, 24.36 mol% Na2O, 25.50 mol% CaO, 
and 3.15 mol% P2O5, sodium metasilicate (Na2SiO3) 
was first extracted from bentonite clay as described 
previously [15]. In a typical sol–gel procedure, 
appropriate amount of the obtained Na2SiO3 was 
dissolved in deionized water to give a solution that was 
then added slowly to 1 M HNO3 in a beaker furnished  
with a magnetic stirrer under ambient temperature for 
1 h to facilitate complete hydrolysis. Thereafter, H3PO4, 
NaNO3, and Ca(NO3)2·4H2O were added under 
constant stirring to give a molar ratio 1:10 of each 
reagent to water in the sol. A reaction time of 45 min 
was allowed for each reagent before adding the next. 
After complete addition, the mixture was further 
stirred for 1 h to afford a gel. The resulting gel was 
aged at room temperature for 3 days, dried at 60 ℃ for 
72 h and 130 ℃ for 42 h, and stabilized at 700 ℃ for 
2 h. Finally, the material was sintered at 950 ℃ for 3 h 
for densification and strengthening of pore struts. 
2. 3    Characterization 
The density of the bioactive glass glass  was calculated from the mass and dimensions of the 
sintered glass. The porosity P was then obtained 
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           (1) 
where s = 2.7 g/cm3 is the theoretical density of 45S5 
Bioglass® [16]. 
The microstructure, composition, and pore size 
distribution of the glass were evaluated in a Phenom 
Prox (Eindhoven, the Netherlands) scanning electron 
microscope (SEM) equiped with energy dispersive 
X-ray analyzer (EDX) before and after immersion in 
simulated body fluid (SBF). The sample was 
carbon-coated and observed at an accelerating voltage 
of 15 kV.   
Samples were characterized using X-ray diffraction 
(XRD) analysis after sintering and after each 
immersion experiment in SBF with the aim of 
assessing the major phase present and the formation of 
hydroxyapatite (HA) crystal on samples’ strut surface 
respectively. The samples were first ground to powder. 
Then 0.1 g of the powder was measured in a 
PANalytical Empyrean X-ray diffractometer using Cu 
Kα radiation source of wavelength λ = 0.154056 nm 
operated at 40 kV and 40 mA to obtain the diffraction 
patterns in the 2θ range from 5° to 90°.  
Fourier transform infrared spectroscopy (FTIR, 
Shimadzu 8400S), with wavenumber range of 
4000–400 cm1 employing KBr pellets and operating in 
a reflectance mode with 4 cm1 resolution, was 
employed to monitor the nature of bonds present in the 
as prepared samples. 





Evaluation of bone bonding ability was carried out by 
the standard in vitro procedure [17]. The acellular 
simulated body fluid (SBF) was prepared        
using analytical reagent-grade chemicals NaCl, 
NaHCO3, KCl, K2HPO4·3H2O, MgCl2·6H2O, CaCl2, 
trishydroxymethyl aminomethane (Tris-buffer, 
(CH2OH)3CNH2), and 1 M HCl with ion 
concentrations shown in Table 1. Samples were 
immersed in the SBF solution at a concentration of 
0.01 g/mL in clean plastic bottles, which were initially 
washed using HCl and deionized water. The bottles 
were placed inside a thermostated incubator at a 
temperature of 36.5 ℃ and an initial pH of 7.4. The 
SBF solutions were not refreshed throughout the 
period of immersion to allow for measurement of pH 
of the solution at different intervals between 0 and 
120 h duration using a pH meter (Hanna, HI96107) 
previously calibrated with buffer solutions of pH = 4.0, 
7.0, and 9.0. The samples were extracted from the SBF 
solution after 3 and 7 days. The extracted samples were 
rinsed with deionized water and left to dry at ambient 
temperature in a desiccator. The formation of apatite 
layer on the glass surface was monitored by SEM, 
EDX, XRD, and FTIR. 
3    Results   
3. 1    Changes in morphology 
The morphology of the glass before and after 
immersion in SBF is shown in Fig. 1. As observed in 
Fig. 1(a), before immersion, the glass presents almost 
uniform porous surface containing mostly 
cuboid-shaped glass architecture well distributed 
throughout the material. The porosity of the glass 
obtained by applying Eq. (1) is 82%. After immersion 
in SBF for 3 days, the glass morphology changes to 
fine grain-sized particles, most of which are 
agglomerated as shown in Fig. 1(b). The EDX 
spectrum during this period of immersion shows a 
decrease in the concentrations of Na, Si, and Ca but an 
increase in P. These changes can be attributed to the 
formation of HA on the surface of the glass. After 
immersion for 7 days in SBF (Fig. 1(c)), the 
micrograph shows dense clusters of HA particles, 
which also appear coarse. Accordingly, the EDX 
spectrum records low detection of Si due to increase in 
population of apatite on the glass surface, while the 
concentrations of Ca and P increase. Furthermore, a 
small carbon peak becomes evident indicating the 
formation of crystalline hydroxycarbonated apatite 
(HCA). 
 
Fig. 1  SEM micrographs with EDX insets of the 
bioactive glass showing the growth of apatite: (a) as 
sintered, (b) after soaking in SBF for 3 days, and (c) after 
soaking in SBF for 7 days. 
Table 1  Ion concentration in human plasma in 
comparison with SBF  (unit: mM) 
Ion Na+ K+ Mg2+ Ca2+ Cl HCO3 HPO42 SO42
SBF 142.0 5.0 1.5 2.5 147.8 4.2 1.0 0.5
Human 
plasma 142.0 5.0 1.5 2.5 103.0 27.0 1.0 0.5
 




The XRD investigation of the glass samples after 
annealing at 950 ℃ for 3 h reveals the presence of 
major peaks of combeite (Na2Ca2Si3O9) crystal usually 
formed from devitrification of quaternary system of 
SiO2–Na2O–CaO–P2O5 bioactive glass [18,19] as 
shown in Fig. 2(a). Both the angular location and 
intensity of the peaks match the standard PDF 
#22.1455. As seen, it is obvious that the glass does not 
fully crystallize judging by the low intensities of the 
Na2Ca2Si3O9 peaks at locations other than the one at 
2θ  30°. Even before immersion in SBF, a peak 
identified as apatite is clearly visible at 2θ  32°. This 
phenomenon has been attributed to the aqueous 
environment of the sol–gel process which favours the 
precipitation of HA from the amorphous structure of 
silica-based bioactive glass [20].  
After immersion in SBF, the intensity of the 
Na2Ca2Si3O9 peaks decreases gradually as shown in 
Figs. 2(a)–2(c). The gradual decrease is an indication 
that the material could have controlled degradation rate 
in physiological fluids, and hence is able to act as 
temporary scaffold prior to complete integration of the 
damaged site, as a major requirement of an ideal 
scaffold for bone repair [21]. Apatite peaks increase as 
immersion duration is prolonged. All apatite positions 
are corroborated by those in the standard PDF JCPDS 
#9-0432. 
3. 3    Assessment of bonds   
The FTIR spectrum of the pristine bioactive glass is 
shown in Fig. 3(a). As observed, there are prominent 
peaks at 3462, 1684, 1458, 1005, 850, 602, and 
457 cm1. The broad band between 3300 and 
3800 cm1 centred at 3462 cm1 is due to OH groups in 
the material, which is further confirmed by the 
presence of water absorbed band around 1684 cm1. 
The band at 1458 cm1 is representative of the 
absorption of carbonate group (ν3), while the sharp 
peak at 1005 cm1 is associated with Si–O–Si 
vibrational modes [22]. The peak at 850 cm1 is 
synonymous with C–O stretching vibration [22], which 
may be due to adsorption of atmospheric CO2 during 
the processing stage of the glass. There is an intense 
peak at 602 cm1 which is assigned to P–O bending 
mode in crystalline calcium phosphate, and another 
small peak at 457 cm1 is attributed to Si–O–Si 
bending vibrations. After immersion for 3 days 
(Fig. 3(b)), the peak at 1458 cm1 becomes broader and 
splits into two modes at 1476 and 1424 cm1, and 
similarly the peak at 602 cm1 develops into two 
modes at 604 and 569 cm1. These are characteristics 
of apatite crystalline phase [23], signalling the 
incorporation of CO32– from the SBF solution into HA 
on the glass surface to form HCA. While after 7-day 
immersion in SBF (Fig. 3(c)), the twin peaks at 604 
and 569 cm1 become more intense due to increase in 
density of HCA on the surface of the glass, thus 
explaining the appearance of the small carbon peak 
observed in the EDX spectrum (Fig. 1(c) inset). 
3. 4    Reactivity in SBF 
Figure 4 shows the pH change of the glass in SBF for 
the first 120 h, which is in agreement with the reaction 
sequence of bioactive glass in biological fluids [5]. As 
observed, there is fast release of alkali and alkaline 
Fig. 2  XRD spectra of the bioactive glass during the 
period of incubation for (a) 0 day, (b) 3 days, and (c) 7 

















Fig. 3  FTIR spectra of the glass immersed in SBF for 
(a) 0 day, (b) 3 days, and (c) 7 days. Similar absorption 
patterns are marked in red doted rectangle.  
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earth ions (Na+ and Ca2+) from the glass into SBF 
solution during the first 4 h leading to an increase in 
pH of the solution from the initial 7.4 to 10.0. The first 
stage of the reaction involves ion-exchange between 
Na+ and Ca2+ of the glass with H+ or H3O+ of the 
solution [18]: 
 
     (2) 
After 4 h, the pH increases slowly until 48 h because 
part of the released Ca2+ from the glass is used to form 
CaO–P2O5, thus decreasing the release rate as shown in 
Fig. 4. As immersion duration reaches 96 h, the pH 
increase slows further as more Ca2+ is withdrawn from 
the SBF solution to develop HCA layer on the surface 
of the glass. Finally, the pH reaches a saturated value 
of 11.7 after 96 h without increasing any further due to 
crystallization of HCA. 
4    Discussion 
4. 1    Composition 
Bentonite clay, a naturally occurring sedimentary clay 
with the chemical formula (OH)4Si8Al4O20 ∙ nH2O,   
has a 3-layer structure displaying one aluminium oxide 
sheet sandwiched by two silicon oxide sheets. The 
arrangement is such that Mg2+ ions may substitute for 
Al3+ ions leaving a net negative charge on the sheets 
[14]. The clay is reacted with NaOH to extract the Si4+ 
ions from the sheets to form Na2SiO3 as filtrate and 
Al(OH)3 as residue as shown in a previous reaction 
scheme [14]. The obtained Na2SiO3 then serves as 
precursor for SiO2 and Na2O for preparing the glass. 
The EDX result of the sintered glass as shown in Fig. 5 
confirms the presence of all the elements in their 
appropriate ratios as prepared. Additionally, a residual 
peak of Al observed in the spectrum may be due to 
incomplete removal of Al(OH)3 from the Na2SiO3 
filtrate during the extraction stage. Hence a more 
efficient filtration method, such as vacuum filtration, 
may be necessary. Apart from bentonite clay, kaolinite 
clay (Al2Si2O5(OH)4) could serve as another cheap 
alternative source of silica.  
4. 2    Microstructure   
The glass exhibits sub-micron pore diameter of mean 
value 2.54 μm (Fig. 6(a)), while the average pore area 
is 0.29 μm2 (Fig. 6(b)). This is expected as clay 
particles themselves have dimensions on nanoscale 
[24,25], thus arrangement of these particles leads to 
evolution of large surface area associated with 
sub-micron pore structure as observed in Fig. 6. The 
microstructure of the glass as well as its porosity    
of 82% are crucial textural parameters for enhanced 
cell adhesion, vascularisation, infiltration, and 
osteointegration on the glass material [26–31]. 
4. 3    Na2Ca2Si3O9 crystalline phase     
The Na2Ca2Si3O9 crystal detected in the XRD 
spectrum (Fig. 2) is the major crystalline phase, and 
displays cuboidal architecture as seen in the SEM 
micrograph shown in Fig. 1(a). During sintering, Na2O, 
CaO, and SiO2 present in the composition react to form 
Na2Ca2Si3O9. Mechanical strength is a significant 
factor in the choice of an ideal scaffold to serve as 
temporary support for new bone growth [31]. While 
there have been concerns about the biodegradability of 
crystalline Na2Ca2Si3O9, some authors have reported 
different scaffold designs and synthetic route 
optimization to improve degradation behaviour of 
Na2Ca2Si3O9 in physiological fluids [31–33]. In the 
+   Na+(aq)S i O N a + +    H + S i O H 








Immersion duration (h) 
Fig. 4  pH change of the glass during immersion in SBF 
for 120 h. 






















Fig. 5  Elemental composition of the parent glass as 
measured by EDX. 
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present work, to ensure partial crystallization, the 
sintering protocol was set at 950 ℃ for 3 h. The 
gradual transformation of the glass from crystalline to 
amorphous after soaking in SBF for 7 days indicates 
biodegradability [26,34–38]. 
4. 4    pH change in SBF   
The steep rise in pH during the first 4 h of soaking in 
SBF indicates high reactivity of the glass. The large 
surface area conferred on the glass by well distributed 
particles and sub-micron-sized pores presents optimal 
sites for ion-exchange reaction to occur. This 
phenomenon explains why apatite nucleation occurs at 
a shorter time, even without immersion in SBF, as 
observed in the spectra for XRD and FTIR in Fig. 2(a) 
and Fig. 3(a) respectively. At the end of 120 h (5 days), 
the pH reaches a value of 11.7 from the initial 7.4 
during which apatite colony increases on the surface of 
the glass as evident by the low detection of Si recorded 
by EDX shown in Fig. 1(a). The basis of bonding 
property of bioactive glass has been anchored on the 
chemical reactivity in physiological body fluids (in 
vitro and in vivo), which leads to the formation of HCA 
layer to which bone can bond.  
5    Conclusions 
The highly bioactive glass in quaternary composition 
has been prepared starting with bentonite clay as silica 
source instead of conventional alkoxysilane precursors. 
The large surface area and micron-sized pore structure 
obtained through the sol–gel processing method were 
key in accelerating the reactivity of the glass in SBF to 
form apatite. The crystalline Na2Ca2Si3O9 formed from 
sintering the glass is important in reinforcing the 
strength of the material during application as scaffold 
in bone repair. Interestingly, the crystalline phase did 
not hinder the biodegradability of the glass in SBF. 
With continuing efforts geared towards cost effective 
design of scaffolds for optimal bioactivity, bentonite 
clay may be a potential cheap raw material for the 
preparation of bioactive glass.  
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